RainDance Technologies, Inc., the Digital Biology™ Company, today announced that it is collaborating with the Hôpital Saint-Louis in Paris, France and BGI in China, the world’s largest genomics institute, to discover new variants and confirm findings from a Rheumatoid Arthritis study conducted by researchers at the Hôpital Saint-Louis.

GlaxoSmithKline (NYSE:GSK) is strengthening its drug pipeline with an experimental arthritis treatment from drug partner ChemoCentryx. The pharmaceutical giant has exercised an option for an exclusive license to develop ChemoCentryx’s investigational drug CCX354, which recently produced positive phase 2 clinical trial results in a study of patients with rheumatoid arthritis. Under terms of the ...

MOUNTAIN VIEW, Calif. , Jan. 5, 2012 /PRNewswire/ -- ChemoCentryx, Inc., today announced that GlaxoSmithKline (GSK) has exercised its option to obtain an exclusive license for further development and worldwide ...

When Callie Phillips, 33, of Harrisburg, was diagnosed with rheumatoid arthritis in February 2006, she said she felt sad and unsure of what her life would be like.

Washington, Jan 2 : Millions suffering from rheumatoid arthritis, asthma, psoriasis and other diseases may find succour in an unexpected source -- lethal toxins produced by the Clostridium botulinum bug, which cause a rare but severe form of food poisoning, could be re-engineered to benefit them, says a new American study.